Schedule 13D ownership disclosure
LONGBOARD PHARMACEUTICALS IN
Security class unavailable · CUSIP: 54300N103
Event date: 2023-02-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,978,540
- Percent of class
- 17.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-23-000056
- Form type
- SC 13D
- Filer
- Longboard Pharmaceuticals, Inc.
- CIK
- CIK 1832168
- Filed
- Mar 27, 2023
- Reporting period
- Feb 07, 2023
- Description
- Schedule 13D beneficial ownership